Knome
Knome, Inc. was a human genome interpretation company based in Cambridge, Massachusetts. Since their 2007 launch, Knome’s sole focus has been on improving lives by applying scientific insights gained from the interpretation of human genomes. Their products and services help their clients identify and classify the variants, genes, and gene sets that are likely to govern or underlie a specific disease, tumor, or drug response. Clients include academic, pharmaceutical and medical researchers. In 2015 it was taken over by Tute Genomics. Technology. Knome has developed proprietary technologies that automate many of the manual tasks involved in interpreting human  whole genomes. These technologies are designed to address the informatics and workflow bottlenecks that typically hinder whole genome interpretation. The company’s core technology, kGAP, was developed in 2009 and serves as the foundation for a number of Knome’s products and services including the knoSYS® platform. Products and services. For academic, pharmaceutical, and medical researchers, Knome offers: